The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.
On Tuesday, a judge formally rejected a motion by the company to have the case dismissed. Carelon Behavioral Health, a subsidiary of Elevance, is accused of publishing an inaccurate directory of providers for those seeking mental health services.
CVS Health has named Roshan Navagamuwa as its new chief information officer to lead the company’s integration with Aetna, which it acquired late last year, The Wall Street Journal reported.
Zebra Medical Vision (Zebra-Med), an Israel-based deep learning imaging analytics company, announced it was granted CE certification for two of its AI-based products intended to speed up clinical review and diagnosis. One is for pneumothorax in chest x-rays and the other helps radiologists detect brain bleeds in CT scans.
Researchers at the Children’s Hospital of Philadelphia (CHOP) developed machine learning models that can detect the presence of sepsis in infants, hours before physicians. Findings from the study were published in PLOS One.
Though AI systems have shown promise for detecting skin cancer, more work is needed before they can be utilized in “real world” applications, according to researchers at the 2019 American Academy of Dermatology annual meeting in Washington, D.C.
The tension that has long simmered between providers and payers across U.S. healthcare is ripe for the easing. And the present moment may offer the best opportunity in decades for all parties to build trust where suspicion has become the default position.
OOVA, a Mount Sinai Health System spinout and diagnostic device company, is piloting an AI-based fertility tool that measures and monitors the concentrations of luteinizing hormone and progesterone—two key fertility hormones. The program is being piloted in collaboration with Thorne Research.
